Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

527.00
-3.3500-0.63%
Post-market: 527.000.00000.00%17:51 EDT
Volume:505.50K
Turnover:267.12M
Market Cap:23.10B
PE:18.92
High:533.73
Open:528.36
Low:524.30
Close:530.35
52wk High:548.12
52wk Low:266.98
Shares:43.83M
Float Shares:41.99M
Volume Ratio:1.04
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.86
EPS(LYR):27.86
ROE:19.71%
ROA:12.42%
PB:3.25
PE(LYR):18.92

Loading ...

Leerink sees MannKind selloff as ‘overreaction’ to headline news

TIPRANKS
·
Feb 26

Liquidia reaction on United Therapeutics’ TreSMI reveal ‘overdone,’ says Needham

TIPRANKS
·
Feb 26

H.C. Wainwright sees MannKind selloff ‘potentially resetting’ value proposition

TIPRANKS
·
Feb 26

Balanced Hold on United Therapeutics Amid Near-Term Pressure and Key Late-Stage Pipeline Readouts

TIPRANKS
·
Feb 26

United Therapeutics announces ‘category killer product’ Tresmi

TIPRANKS
·
Feb 26

MannKind sinks after United Therapeutics announces soft-mist inhaler

TIPRANKS
·
Feb 26

Stock Track | United Therapeutics Soars 5.19% Intraday on Strong Q4 Earnings Beat and Tyvaso Growth

Stock Track
·
Feb 25

United Therapeutics Q4 revenue growth falls short of analyst expectations

Reuters
·
Feb 25

United Therapeutics reports Q4 EPS $7.70, consensus $7.24

TIPRANKS
·
Feb 25

Earnings Flash (UTHR) United Therapeutics Posts Q4 EPS $7.70, vs. FactSet Est of $6.67

MT Newswires Live
·
Feb 25

United Therapeutics Q4 EPS $7.70 Beats $7.09 Estimate, Sales $790.200M Miss $813.077M Estimate

Benzinga
·
Feb 25

BRIEF-United Therapeutics Q4 Revenue USD 790.2 Million Vs. IBES Estimate USD 813.1 Million

Reuters
·
Feb 25

United Therapeutics Q4 Revenue USD 790.2 Million VS. Ibes Estimate USD 813.1 Million

THOMSON REUTERS
·
Feb 25

United Therapeutics Q4 Net Income USD 364.3 Million

THOMSON REUTERS
·
Feb 25

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS
·
Feb 25

U.S. Earnings Preview: Before Market Open Feb. 25

Dow Jones
·
Feb 25

United Therapeutics President and COO Michael Benkowitz Disposes of Common Shares

Reuters
·
Feb 25

United Therapeutics President and COO Michael Benkowitz to Present at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 23

United Therapeutics EVP and General Counsel Paul A. Mahon Disposes of Common Shares

Reuters
·
Feb 20

United Therapeutics President and COO Michael Benkowitz Disposes of Common Shares

Reuters
·
Feb 19